These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5487697)

  • 1. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative evaluation of hemodynamics and the functional state of the liver in cirrhosis].
    Anisimova SM
    Vestn Khir Im I I Grek; 1972 Dec; 109(12):32-5. PubMed ID: 4664077
    [No Abstract]   [Full Text] [Related]  

  • 4. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic disorders due to liver cirrhosis].
    Garbuzenko DV
    Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of development of portal hypertension in liver cirrhosis].
    Kalashnikov SA
    Klin Med (Mosk); 1975 Apr; 53(4):74-8. PubMed ID: 1152376
    [No Abstract]   [Full Text] [Related]  

  • 9. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of portal hypertensive gastropathy: an unresolved issue.
    Lo GH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1482-3. PubMed ID: 19743994
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of sinusoidal perfusion in portal hypertension.
    Reynaert H; Urbain D; Geerts A
    Anat Rec (Hoboken); 2008 Jun; 291(6):693-8. PubMed ID: 18484616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
    Zhang TL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial dysfunction in cirrhosis.
    Iwakiri Y; Groszmann RJ
    J Hepatol; 2007 May; 46(5):927-34. PubMed ID: 17391799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug treatment for portal hypertension due to cirrhosis].
    Lebrec D; Benhamou JP
    Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Splenic hemodynamics and portal hypertension in splenomegalic hepatic cirrhosis].
    Merkel C; Gatta A; Arnaboldi L; Zuin R
    G Clin Med; 1983 Nov; 64(11):465-74. PubMed ID: 6667802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.